BioXcel Therapeutics
BTAI
BTAI
48 hedge funds and large institutions have $3.21M invested in BioXcel Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 10 closing their positions.
Holders
48
Holders Change
-2
Holders Change %
-4%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
11
Reduced
17
Closed
10
Calls
$23K
Puts
$28K
Net Calls
-$5K
Net Calls Change
+$7K
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$1.61M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$478K |
| 3 |
3
Squarepoint
New York
|
$26.9K |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$27.6K |
| 5 |
HF
5
HRT Financial
New York
|
$9K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFM
51
Catalyst Funds Management
Sydney NSW,
Australia
| – | – | -5,200 | Closed |
|
|
AWM
52
AllSquare Wealth Management
Albany,
New York
| – | – | -4,527 | Closed |
|
53
Simplex Trading
Chicago,
Illinois
| – | – | -3,113 | Closed |
|
|
TFA
54
Toth Financial Advisory
Leesburg,
Virginia
| – | – | -500 | Closed |
|
|
TFGT
55
TS Financial Group (TSFG)
Lake Forest,
Illinois
| – | – | -150 | Closed |
|
56
Citigroup
New York
| – | – | -3 | Closed |
|
|
HFS
57
Hantz Financial Services
Southfield,
Michigan
| $0 | 50 | – | – |
|
|
CFGS
58
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
59
Barclays
London,
United Kingdom
| $0 | 88 | – | – |
|
60
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|